Haematopoietic Stem Cell Transplants: Expanding beyond malignancies

September 12, 2013


In both children and adults, allogeneic haematopoietic stem cell transplants (HSCTs), also known as bone marrow transplants, allow specialists to eradicate a patient's bone marrow and immune system in order to replace it with those of another for the treatment of a wide variety of diseases. First attempted more than 55 years ago to treat patients suffering from leukemia and other haematologic malignancies, over the decades the list of pediatric indications for allogeneic HSCTs has expanded considerably. 

Dr. Leslie Lehmann, Clinical Director of the Stem Cell Transplant Center at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, discusses recent advances in Arab Health Magazine.

Media Inquiries

Irene Sege
Senior Media Relations Specialist

Follow Us!

Stay updated on our latest news and developments by following us on Twitter.

Twitter Logo